Vermont Psychological Services: Leitenberg Center For Evidence-based P - Medicare Mental Health Clinic in Burlington, VT

Vermont Psychological Services: Leitenberg Center For Evidence-based P is a medicare enrolled mental health clinic (Psychologist - Clinical) in Burlington, Vermont. The current practice location for Vermont Psychological Services: Leitenberg Center For Evidence-based P is 2 Colchester Avenue, Burlington, Vermont. For appointments, you can reach them via phone at (802) 656-2661. The mailing address for Vermont Psychological Services: Leitenberg Center For Evidence-based P is 2 Colchester Avenue, Burlington, Vermont and phone number is (802) 656-2661.

Vermont Psychological Services: Leitenberg Center For Evidence-based P is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1598837593. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (802) 656-2661.

Contact Information

Vermont Psychological Services: Leitenberg Center For Evidence-based P
2 Colchester Avenue
Burlington
VT 05405-1764
(802) 656-2661
(802) 656-3485

Mental Health Clinic Profile

Full NameVermont Psychological Services: Leitenberg Center For Evidence-based P
SpecialityPsychologist
Location2 Colchester Avenue, Burlington, Vermont
Authorized Official Name and PositionKathleen B. Kennedy (ACTING DIRECTOR)
Authorized Official Contact8026562661
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Vermont Psychological Services: Leitenberg Center For Evidence-based P
2 Colchester Avenue
Burlington
VT 05405-1764

Ph: (802) 656-2661
Vermont Psychological Services: Leitenberg Center For Evidence-based P
2 Colchester Avenue
Burlington
VT 05405-1764

Ph: (802) 656-2661

NPI Details:

NPI Number1598837593
Provider Enumeration Date11/14/2006
Last Update Date02/03/2017

Medicare PECOS Information:

Medicare PECOS PAC ID0244277333
Medicare Enrollment IDO20050411000605

News Archive

New findings on myotonic muscular dystrophy

New research from the University of Virginia Health System shows that, in cases of Type 1 myotonic muscular dystrophy (DM1), a well known heart protein does several surprising things. DM1 is the most common form of muscular dystrophy in adults and affects approximately 40,000 adults and children in the U.S.

American voters say U.S. support for WHO important, poll shows

"Nine in 10 U.S. voters say it's important for the United States to support the global health efforts of the U.N.'s World Health Organization, according to a United Nations Foundation/Better World Campaign poll released Thursday," The Hill's "Global Affairs" blog reports.

Scientists develop new chemo drug that fights cancer without impacting fertility

A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine- scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.

Evotec to collaborate with Merck on neurological disease drug discovery program

Evotec AG today announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery expertise covering in vitro biology, medicinal chemistry and in vitro and in vivo pharmacology.

Read more Medical News

› Verified 7 days ago

Medical Identifiers

Medical identifiers for Vermont Psychological Services: Leitenberg Center For Evidence-based P such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1598837593NPI-NPPES
2820OtherVTBCBS OF VT
2820OtherVTBCBS
0002820MedicaidVT

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103TC0700XPsychologist - Clinical (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Vermont Psychological Services: Leitenberg Center For Evidence-based P acts as a billing entity for following providers:
Provider NameLee D Rosen
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1396796439
PECOS PAC ID: 2668482373
Enrollment ID: I20060426000067

News Archive

New findings on myotonic muscular dystrophy

New research from the University of Virginia Health System shows that, in cases of Type 1 myotonic muscular dystrophy (DM1), a well known heart protein does several surprising things. DM1 is the most common form of muscular dystrophy in adults and affects approximately 40,000 adults and children in the U.S.

American voters say U.S. support for WHO important, poll shows

"Nine in 10 U.S. voters say it's important for the United States to support the global health efforts of the U.N.'s World Health Organization, according to a United Nations Foundation/Better World Campaign poll released Thursday," The Hill's "Global Affairs" blog reports.

Scientists develop new chemo drug that fights cancer without impacting fertility

A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine- scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.

Evotec to collaborate with Merck on neurological disease drug discovery program

Evotec AG today announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery expertise covering in vitro biology, medicinal chemistry and in vitro and in vivo pharmacology.

Read more Medical News

› Verified 7 days ago

Provider NameLauren M Dewey
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1124337837
PECOS PAC ID: 1456686625
Enrollment ID: I20190710001272

News Archive

New findings on myotonic muscular dystrophy

New research from the University of Virginia Health System shows that, in cases of Type 1 myotonic muscular dystrophy (DM1), a well known heart protein does several surprising things. DM1 is the most common form of muscular dystrophy in adults and affects approximately 40,000 adults and children in the U.S.

American voters say U.S. support for WHO important, poll shows

"Nine in 10 U.S. voters say it's important for the United States to support the global health efforts of the U.N.'s World Health Organization, according to a United Nations Foundation/Better World Campaign poll released Thursday," The Hill's "Global Affairs" blog reports.

Scientists develop new chemo drug that fights cancer without impacting fertility

A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine- scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.

Evotec to collaborate with Merck on neurological disease drug discovery program

Evotec AG today announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery expertise covering in vitro biology, medicinal chemistry and in vitro and in vivo pharmacology.

Read more Medical News

› Verified 7 days ago

News Archive

New findings on myotonic muscular dystrophy

New research from the University of Virginia Health System shows that, in cases of Type 1 myotonic muscular dystrophy (DM1), a well known heart protein does several surprising things. DM1 is the most common form of muscular dystrophy in adults and affects approximately 40,000 adults and children in the U.S.

American voters say U.S. support for WHO important, poll shows

"Nine in 10 U.S. voters say it's important for the United States to support the global health efforts of the U.N.'s World Health Organization, according to a United Nations Foundation/Better World Campaign poll released Thursday," The Hill's "Global Affairs" blog reports.

Scientists develop new chemo drug that fights cancer without impacting fertility

A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine- scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.

Evotec to collaborate with Merck on neurological disease drug discovery program

Evotec AG today announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery expertise covering in vitro biology, medicinal chemistry and in vitro and in vivo pharmacology.

Read more News

› Verified 7 days ago

Psychologist in Burlington, VT

Natalie Zimmer Counseling, Lcmhc, Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 92 Adams St, Burlington, VT 05401
Phone: 802-734-8757    
C. Emma Burrous, Ph.d., Plc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 118 Pine St, Burlington, VT 05401
Phone: 802-657-4042    Fax: 802-862-4062
Distancetherapy.com
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 130 Mansfield Ave Apt 201, Burlington, VT 05401
Phone: 802-448-3954    
F J Losch Counseling Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 990 Pine St, Burlington, VT 05401
Phone: 802-448-4226    
Justin Dragos Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 337 College St, Burlington, VT 05401
Phone: 802-233-8495    
Neurological Associates Of Vt
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 89 S Williams St, Burlington, VT 05401
Phone: 802-862-5759    Fax: 802-658-0680
Duncan Fox Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 156 College St Ste 201, Burlington, VT 05401
Phone: 802-310-1408    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.